Skip to main content
Fig. 2 | BMC Psychiatry

Fig. 2

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Fig. 2

Mean score of Y-BOCS, BAI, and BDI-II before and after rTMS treatment in responders and nonresponders to rTMS (a). Mean score of Y-BOCS, BAI, and BDI-II before and after rTMS treatment in participants who received SMA or DLPFC rTMS (b). Percentage of response (c) and percentage of OCD symptoms decrease (d) in all patients and based on the intervention protocol. In graphs C and D, only post-intervention scores are compared. Note: Y-BOCS = Yale-Brown Obsessive-Compulsive Scale; BAI = Beck Anxiety Inventory; BDI-II = Beck Depression Inventory; * = statistically significant; ns = non-significant; All error bars represent standard error of the mean (S.E.M). Pairwise comparisons were conducted using the Bonferroni-corrected post hoc t-test

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us